News and Trends 25 May 2021 Delayed IPOs and Market Drops Batter Biotech Stocks …the Netherlands and bluebird bio in the US, gene therapy trials were paused to investigate cancer cases in a few patients. A trial of a Parkinson’s disease gene therapy developed… May 25, 2021 - 6 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Startup Scout 29 Mar 2019 This Biotech Repurposes Drugs to Fight Huntington’s Disease …Benevolent AI repurposing treatments for Parkinson’s disease. However, Insa told me that SOM Biotech’s technology is three times better at predicting suitable drugs than competitor companies. The company identified an… March 29, 2019 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 2 Apr 2025 Top biotech deals of March 2025 …together to boost the phase 3 trials of the latter’s AAV-GAD program for Parkinson’s disease. MeiraGTx will bank $200 million upfront. The two will form a joint venture, Hologen Neuro… April 2, 2025 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 10 Sep 2021 The Top European Biotech Funding Rounds in August …metabolic diseases involving the liver. And NRG Therapeutics in the UK closed a small seed investment of around £490,000 (€570,000) in a bid to treat Parkinson’s disease. One interesting seed… September 10, 2021 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Mar 2024 Can AbbVie’s legacy live beyond its once best-selling drug Humira? …Cerevel Therapeutics, a biotech focused on developing drugs to treat psychiatric and neurological disorders. However, the deal with Cerevel has spurred antitrust scrutiny as the latter has Parkinson’s and schizophrenia… March 7, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2025 Top biotech deals in September 2025 …synucleinopathies, a group of neurodegenerative diseases characterized by the abnormal accumulation of alpha-synuclein protein like Parkinson’s disease. Arrowhead will haul in $200 million upfront and is eligible to receive up… October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2017 A Brand New Outlook on Induced Pluripotent Stem Cells …or dopaminergic neurons in the case of Parkinson’s disease. These cells shall then be transplanted into patients to replace their own cells that might be defective, reduced in number, or… July 17, 2017 - 8 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 13 Aug 2019 AskBio Acquires Scottish Biotech to Make Gene Therapies More Precise …the pipeline, including a phase I/II gene therapy for Parkinson’s disease, and another in phase I/II for the rare neuromuscular disease Pompe disease. Synpromics also has ongoing partnerships with big… August 13, 2019 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Best in Biotech 11 Jul 2024 From data to discovery: Five bioinformatics companies you should know in 2024 …its AI-enabled platform. In the discovery stage, it is developing drugs to treat Parkinson’s disease, schizophrenia, psoriasis, atopic dermatitis, Crohn’s disease, and ulcerative colitis. It also has a partnered ALS… July 11, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 9 Nov 2023 Blood tests for Alzheimer’s: a hit or a miss? …into the market last year, and is used to detect signs of other neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), dementia, concussions and Parkinson’s disease, as well. Labcorp is among… November 9, 2023 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 17 Jul 2018 Gene Therapy Could Prevent Deadly Brain Disease …risk for Parkinson’s disease. The study, published in Nature Medicine, showed mice fetuses with Gaucher disease that received an injection of the gene therapy were able to express the missing… July 17, 2018 - 3 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 Dec 2020 A Year to Remember: The Biggest European Biotech News in 2020 …AI chips that rewire us to treat conditions like Parkinson’s disease. The German firm CureVac started the development of a vaccine for the emerging viral disease Covid-19. CureVac’s candidate is… December 28, 2020 - 12 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email